Department of Otolaryngology, Washington University School of Medicine in St. Louis, MO.
Amptify, St. Louis, MO.
Am J Audiol. 2022 Sep 21;31(3S):905-913. doi: 10.1044/2022_AJA-21-00236. Epub 2022 Aug 29.
A digital therapeutic is a software-based intervention for a disease and/or disorder and often includes a daily, interactive curriculum and exercises; online support from a professional versed in the treatment base; and an online support community, typically active as a social chat group. Recently, the Consumer Technology Association published revised standards for digital therapeutics (DTx) that stipulate that a DTx must be evidence based and founded in scientific evidence showing effectiveness and must be supported by evidence showing improved patient satisfaction and adherence to an intervention. The purpose of this study was to investigate whether a DTx could help older adults better adjust to their hearing loss and acclimate to new hearing aids.
Thirty older adults with mild or moderate hearing loss who had never used hearing aids participated. All hearing aids were fitted remotely. Participants used a hearing health care DTx (Amptify) for 4 weeks, either immediately following receipt of the hearing aids or 4 weeks after the fitting. A control condition was watching closed caption television. Participants completed a satisfaction questionnaire that queried about their impressions of the DTx, which had items that included both a rating scale of 1-7 and open-ended questions.
Ninety-six percent of the participants reported positive benefits, and one-half reported that the DTx helped them to adjust to their new hearing aids. They assigned a score of 5.8 to one of the questionnaire items that is similar to a Net Promoter Score Benefits, which included an enhanced ability to engage in conversation and increased listening confidence.
This investigation provides scientific evidence to support the use of a hearing health care DTx, paving the way for audiologists to be able to more easily and efficiently incorporate follow-up aural rehabilitation into their routine clinical services and to be able to provide services remotely.
数字疗法是一种针对疾病和/或障碍的基于软件的干预措施,通常包括每日互动课程和练习;由精通治疗基础的专业人员提供在线支持;以及一个在线支持社区,通常以社交聊天组的形式活跃。最近,消费者技术协会发布了修订后的数字疗法 (DTx) 标准,规定 DTx 必须基于证据,并基于有效性的科学证据,并且必须有证据表明患者满意度和对干预措施的依从性得到提高。本研究旨在调查数字疗法是否可以帮助老年人更好地适应听力损失并适应新的助听器。
30 名从未使用过助听器的轻度或中度听力损失的老年人参与了研究。所有助听器均通过远程适配。参与者使用听力保健数字疗法(Amptify)进行了 4 周的治疗,一种是在收到助听器后立即使用,另一种是在适配 4 周后使用。对照组为观看闭路字幕电视。参与者完成了一份满意度问卷,询问他们对 DTx 的印象,其中包括一个 1-7 的评分量表和开放式问题。
96%的参与者报告了积极的益处,一半的参与者报告说 DTx 帮助他们适应了新的助听器。他们给问卷中的一个项目打了 5.8 分,这个项目类似于净推荐值效益,其中包括提高了参与对话的能力和增强了听力信心。
本研究为使用听力保健数字疗法提供了科学证据,为听力学家能够更轻松、更有效地将后续听觉康复纳入其常规临床服务,并能够提供远程服务铺平了道路。